Significant Ownership of SAMLYN CAPITAL, LLC
- Signature - Title
- By: Samlyn, LP, its sole member, By: Samlyn GP, LLC, its general partner, /s/ Robert Pohly* - Robert Pohly / Managing Member
- Location
- New York, NY
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by SAMLYN CAPITAL, LLC.
Follow Filing Activity
Follow SAMLYN CAPITAL, LLC and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of SAMLYN CAPITAL, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PCT | PureCycle Technologies, Inc. | Common Stock, par value $0.001 per share | 7.2% | $179,440,876 | -$40,162,309 | 13,645,694 | -18% | Samlyn Capital, LLC | 30 Sep 2025 |
| VINP | Vinci Partners Investments Ltd. | Class A Common Shares, par value US$0.00005 per share | 4.8% | $22,695,339 | -$34,013 | 2,356,733 | -0.15% | SAMLYN CAPITAL, LLC | 31 Mar 2025 |
| NKTR | Nektar Therapeutics | Common Stock, $0.0001 par value | 0% | $0 | -$7,153,616 | 0 | -100% | SAMLYN CAPITAL, LLC | 31 Mar 2025 |
| CRVS | Corvus Pharmaceuticals, Inc. | Common Stock, par value $0.0001 per share | 0% | $0 | -$15,857,146 | 0 | -100% | SAMLYN CAPITAL, LLC | 30 Jun 2025 |
| INZY | Inozyme Pharma, Inc. | Common Stock, par value $0.0001 per share | 0% | $0 | 0 | Samlyn Capital, LLC | 31 Dec 2024 |
Schedules 13D/G Reported by SAMLYN CAPITAL, LLC:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.